SCHEMBL21974098

SCHEMBL21974098

c1ccc(-c2cc(-c3cc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)cc(-c4cc(-c5ccccc5)nc(-c5ccccc5)c4)c3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.49
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
MCL1 Q07820 2/20 0.44
RAB9A P51151 1/20 0.43
CTRC Q99895 1/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
ADORA1 P30542 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ADORA2A P29274 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MYC P01106 1/20 0.42
MAPT P10636 3/20 0.42
NTSR1 P30989 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA2B P29275 1/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18904080 0.98 CYP19A1 (0.50) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL13203159 0.98 CYP19A1 (0.50) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL4360069 0.98 CYP19A1 (0.50) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL21974088 0.96 CYP19A1 (0.49) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL13203171 0.96 CYP19A1 (0.52) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL21974094 0.90 MEN1 (0.53) CYP19A1MEN1KMT2AMCL1CTRC
SCHEMBL19287928 0.90 MEN1 (0.62) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL2623297 0.89 CYP19A1 (0.42) CYP19A1MEN1KMT2AMCL1RAB9A
SCHEMBL21973896 0.88 MEN1 (0.54) MEN1KMT2ACTRCALDH1A1HPGD
SCHEMBL17942883 0.88 MCL1 (0.55) CYP19A1MEN1KMT2AMCL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140416-A1 COMPOUND, OLED DISPLAY PANEL AND ELECTRONIC DEVICE OCIAD2, OCIAD1, EED CYP19A1 727/4885MEN1 3967/4885KMT2A 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.